...drop to drink! Is the real cost of bottled water beyond the benefits? 
The World Wildlife Federation (WWF) estimates that annual consumption of bottled water is estimated to be around 89 billion litres. While the US is the biggest consumer of bottled water, the global bottled water consumption has doubled between 1997 and 2005. In the same period, India’s consumption has tripled and China’s doubled. Ling Li, in his report for Washington-based Worldwatch Institute, estimates that bottled water costs from 240 to 10,000 times more than tap water. That means in dollar terms, most industrialised countries spend $500 to $1,000 dollars per cubic metre of bottled water compared to, say, 50 cents per cubic metre tap water in the state of California.
For Complete IIPM Article, Click on IIPM Article
The World Wildlife Federation (WWF) estimates that annual consumption of bottled water is estimated to be around 89 billion litres. While the US is the biggest consumer of bottled water, the global bottled water consumption has doubled between 1997 and 2005. In the same period, India’s consumption has tripled and China’s doubled. Ling Li, in his report for Washington-based Worldwatch Institute, estimates that bottled water costs from 240 to 10,000 times more than tap water. That means in dollar terms, most industrialised countries spend $500 to $1,000 dollars per cubic metre of bottled water compared to, say, 50 cents per cubic metre tap water in the state of California.
For Complete IIPM Article, Click on IIPM Article
Source : IIPM Editorial, 2007
An IIPM and Professor Arindam Chaudhuri (Renowned Management Guru and Economist) Initiative
acquiring Taro Pharmaceutical Industries Ltd. The deal (worth $454 million) will be funded with interior accumulation and proceeds from its FCCB. This multinational has its footprints in U.S., Israel and Canada, of which North America begets more than 90% of Taro’s sales. Dilip Shanghvi, Sun CMD, stated that the company looks forward to working with Taro and its employees further ahead. It’s the apt opportunity for the duo to create increasing value and add a complimentary multinational organization to Sun’s business. More so to the deal, there are bright chances to build on Taro’s expertise in dermatology and paediatrics, along with its speciality and generic pharmaceuticals and over-the-counter products.
